A new bill, the Dietary Supplement Listing Act of 2022, would create the impression of reform in the supplement industry while leaving the current lax regulatory framework largely untouched.
Funding and Disclosures
Disclosure forms provided by the authors are available at NEJM.org.
This article was published on May 18, 2022, at NEJM.org.
Print Subscriber? Activate your online access.